These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 25089954)
41. Dopamine D2 receptor TaqIA and TaqIB polymorphisms in Parkinson's disease. Tan EK; Tan Y; Chai A; Tan C; Shen H; Lum SY; Fook-Cheong SM; Teoh ML; Yih Y; Wong MC; Zhao Y Mov Disord; 2003 May; 18(5):593-5. PubMed ID: 12722176 [TBL] [Abstract][Full Text] [Related]
42. Genetic variants of D2 but not D3 or D4 dopamine receptor gene are associated with rapid onset and poor prognosis of methamphetamine psychosis. Ujike H; Katsu T; Okahisa Y; Takaki M; Kodama M; Inada T; Uchimura N; Yamada M; Iwata N; Sora I; Iyo M; Ozaki N; Kuroda S Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):625-9. PubMed ID: 19275926 [TBL] [Abstract][Full Text] [Related]
43. DRD2 Genotype-Based Variants Modulates D2 Receptor Distribution in Ventral Striatum. Valli M; Cho SS; Masellis M; Chen R; Rusjan P; Kim J; Koshimori Y; Mihaescu A; Strafella AP Mol Neurobiol; 2019 Sep; 56(9):6512-6520. PubMed ID: 30847741 [TBL] [Abstract][Full Text] [Related]
44. Endogenous dopamine lowers the dopamine D2 receptor density as measured by [3H]raclopride: implications for positron emission tomography of the human brain. Seeman P; Guan HC; Niznik HB Synapse; 1989; 3(1):96-7. PubMed ID: 2521961 [No Abstract] [Full Text] [Related]
45. No association of dopamine receptor sensitivity in vivo with genetic predisposition for alcoholism and DRD2/DRD3 gene polymorphisms in alcohol dependence. Wiesbeck GA; Dürsteler-MacFarland KM; Wurst FM; Walter M; Petitjean S; Müller S; Wodarz N; Böning J Addict Biol; 2006 Mar; 11(1):72-5. PubMed ID: 16759339 [TBL] [Abstract][Full Text] [Related]
47. A genetic determinant of the striatal dopamine response to alcohol in men. Ramchandani VA; Umhau J; Pavon FJ; Ruiz-Velasco V; Margas W; Sun H; Damadzic R; Eskay R; Schoor M; Thorsell A; Schwandt ML; Sommer WH; George DT; Parsons LH; Herscovitch P; Hommer D; Heilig M Mol Psychiatry; 2011 Aug; 16(8):809-17. PubMed ID: 20479755 [TBL] [Abstract][Full Text] [Related]
48. Alterations in DNA-methylation of the dopamine-receptor 2 gene are associated with abstinence and health care utilization in individuals with a lifetime history of pathologic gambling. Hillemacher T; Frieling H; Buchholz V; Hussein R; Bleich S; Meyer C; John U; Bischof A; Rumpf HJ Prog Neuropsychopharmacol Biol Psychiatry; 2015 Dec; 63():30-4. PubMed ID: 26028496 [TBL] [Abstract][Full Text] [Related]
49. Frontostriatal involvement in task switching depends on genetic differences in d2 receptor density. Stelzel C; Basten U; Montag C; Reuter M; Fiebach CJ J Neurosci; 2010 Oct; 30(42):14205-12. PubMed ID: 20962241 [TBL] [Abstract][Full Text] [Related]
50. Genetic variations in the dopamine reward system influence exercise reinforcement and tolerance for exercise intensity. Flack K; Pankey C; Ufholz K; Johnson L; Roemmich JN Behav Brain Res; 2019 Dec; 375():112148. PubMed ID: 31404557 [TBL] [Abstract][Full Text] [Related]
51. DRD2: Bridging the Genome and Ingestive Behavior. Sun X; Luquet S; Small DM Trends Cogn Sci; 2017 May; 21(5):372-384. PubMed ID: 28372879 [TBL] [Abstract][Full Text] [Related]
52. DRD2 Ser311Cys polymorphism and risk of schizophrenia. Watanabe Y; Shibuya M; Someya T Am J Med Genet B Neuropsychiatr Genet; 2015 Apr; 168B(3):224-8. PubMed ID: 25711927 [No Abstract] [Full Text] [Related]
53. On the genetics of loss aversion: An interaction effect of BDNF Val66Met and DRD2/ANKK1 Taq1a. Voigt G; Montag C; Markett S; Reuter M Behav Neurosci; 2015 Dec; 129(6):801-11. PubMed ID: 26501178 [TBL] [Abstract][Full Text] [Related]
55. Response to "DRD2 Ser311Cys polymorphism and risk of schizophrenia". Yao J; Wang BJ Am J Med Genet B Neuropsychiatr Genet; 2015 Apr; 168B(3):223. PubMed ID: 25711779 [No Abstract] [Full Text] [Related]
56. Comment on "Genetically determined differences in learning from errors". Lucht M; Rosskopf D Science; 2008 Jul; 321(5886):200; author reply 200. PubMed ID: 18621654 [TBL] [Abstract][Full Text] [Related]
57. Commentary on Boileau et al. (2013): Distinguishing D2/D3 dopaminergic contributions to addictions. Potenza MN; Brody AL Addiction; 2013 May; 108(5):964-5. PubMed ID: 23587083 [No Abstract] [Full Text] [Related]
58. Gene-environment interactions across development: Exploring DRD2 genotype and prenatal smoking effects on self-regulation. Wiebe SA; Espy KA; Stopp C; Respass J; Stewart P; Jameson TR; Gilbert DG; Huggenvik JI Dev Psychol; 2009 Jan; 45(1):31-44. PubMed ID: 19209988 [TBL] [Abstract][Full Text] [Related]
59. Addiction-related genes in gambling disorders: new insights from parallel human and pre-clinical models. Lobo DS; Aleksandrova L; Knight J; Casey DM; el-Guebaly N; Nobrega JN; Kennedy JL Mol Psychiatry; 2015 Aug; 20(8):1002-10. PubMed ID: 25266122 [TBL] [Abstract][Full Text] [Related]